The Netherlandsmsd-animal-health.com
Intervet International B.V. is a key company in the veterinary pharmaceutical industry, focusing on the development and supply of vaccines and medicines for livestock and companion animals. The firm conducts extensive research into animal diseases and produces innovative products such as the Bovilis series of vaccines used for preventing conditions like lumpy skin disease in cattle.
Main activities include manufacturing, quality control, and global distribution of these health products. Intervet operates from its base in the Netherlands and maintains facilities and operations in various countries to serve markets in Europe, North America, Asia, and beyond.
The company is a subsidiary of Merck & Co., Inc., which is known as MSD outside the US, and it operates within the MSD Animal Health segment. This affiliation provides it with significant resources for research and expansion while allowing it to specialize in animal health solutions.
In the broader industry, Intervet is positioned as a major contributor to animal health management, helping to enhance productivity in farming and ensure the well-being of pets. It collaborates with regulatory authorities to bring safe and effective products to market, supporting efforts in disease control and prevention worldwide.
Intervet plays a vital role in the animal health sector by providing solutions that help prevent outbreaks of infectious diseases in animal populations, thereby supporting food security and public health indirectly through its global operations.
None yet. When a new project in the record names Intervet as owner, partner or investor, it shows here.
Live attenuated vaccine cuts clinical signs and viraemia from three weeks post‑vaccination and confers protection for one year; authorised under exceptional circumstances; side effects are uncommon.
